OOIR: Observatory of International Research

Papers

(The median citation count of Biosocieties is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	15
Sexual health as surplus: the marketization of PrEP in Taiwan	13
When sociality fails to produce solidarity: environmental NGOs and the politics of public engagement in contemporary China	12
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation	12
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests	11
Discipline for pleasure: a new governmentality of HIV prevention	11
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time	11
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies	10
Mapping ‘bio geo-body’ of Southeast Asia: strategic differentiation and identification of ethnic identity in Vietnam and Singapore	10
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	8
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence	8
Making sense of snakebite: the place of biological toxins in social scientific analyses of toxicity	8
Bleak Biopolitics and Abolitionist Aspirations: Recent Books on Race	8
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities	7
Post-identifiability in changing sociotechnological genomic data environments	7
Epistemology of the side effect: anecdote and evidence in the digital age	6
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar	6
Challenges in public policy for the implementation of pharmacogenetic tests in Europe	6
Making death through producing life: Necrovalue and the political economy of death	5
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs	5
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices	5
It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’	5
Openness in donor conception families	5
Our thanks to founding editor Professor Nikolas Rose	4
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building	4

Negotiating the necessity of biomedical animal use through relations with vulnerability	4
Value-creation in the health data domain: a typology of what health data help us do	4
Correction to: The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	4
Psychedelic innovations and the crisis of psychopharmacology	4
Allostatic load: historical origins, promises and costs of a recent biosocial approach	4
Population anxieties in constituting Nordic welfare state futures: affective biopolitics in the age of environmental crises	3
Donors we choose: race, nation and the biopolitics of (queer) assisted reproduction in Scandinavia	3
Foetal programming meets human capital: biological plasticity, development, and the limits to the economization of life	3
Afterword: the politics of suspension as an analytical gestalt switch	3
“Is your brain in danger of overheating?”: neurobiologizing the labouring subject in cognitive capitalism	3
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016–2020	3
Navigating biosafety concerns within COVID-19 do-it-yourself (DIY) science: an ethnographic and interview study	3
Correction to: Epidemiologists’ ambivalence towards the epigenetics of social adversity	3
Making valuable health: pharmaceuticals, global capital and alternative political economies	2
Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	2
Diversity via datafication? Digital patient records and citizenship for sexuality and gender diverse people	2
‘Nonetheless biosocial’: experiences and embodied knowledge of birth cohort participants in the UK and Brazil	2
Correction: Reproducing the normal and the pathological in personalized cancer medicine clinical trials	2
Good donors, bad donors and oddities in the family tree: genomics, donation and reproductive citizenship in Finnish egg donor accounts	2
The normal is pathological: semi-conscious brains, mindless habits, and the paradoxical science of mindfulness	2
Antibiotics in the environment: molecularisation, drug resistance and pharmaceutical pollution in India	2
Microbial eccentricity: more-than-human creativity in anthropoeccentric worlds	2
Anticipating and suspending: the chronopolitics of cryopreservation	2
Formatting patient knowledge and channelling participation: how patient organisations work under authoritarianism	2
Inscrutable futures: biotechnology, architecture, and planetary ecology in late industrial China	2
Correction: Core values of genomic citizen science: results from a qualitative interview study	1
More than sample providers: how genetic researchers in Pakistan mobilized a prenatal diagnostic service for thalassemia	1
Reproducing the normal and the pathological in personalized cancer medicine clinical trials	1
The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	1
Guardians of ableist family formation: the legitimation work of Danish abortion committees in cases of termination for fetal anomaly	1
The emergence of multimorbidity as a matter of concern: a critical review	1
To wish you well: the biopolitical subjectivities of medical crowdfunders during and after Aotearoa New Zealand’s COVID-19 lockdown	1
The effects of COVID-19 on imagined reproductive futures	1
‘Healthy’ for whom? ‘Healthy’ food’s effectivities, avocados, and the production of differentiated bodies	1
‘Our biology is listening’: biomarkers as molecular vestiges of early life and the production of positive childhood experiences in behavioral epigenetics	1
“Being useful, I think it's the result of a sick society”: Critical reflections on reproductive politics and markets by women freezing their eggs in Spain	1
Chronic pain across clinical settings: the changing understanding of pain and its treatment in endometriosis	1
Making epistemic goods compatible: knowledge-making practices in a lifestyle intervention RCT on mindfulness and compassion meditation	1
In whose pockets? How small Danish patient organisations balance legitimacy, representation and dependency in collaboration with public sector medical researchers and the life science industry	1
Profit and power: negotiating medical authority and an informed consumer-patient in transgender surgery	1
Reprowebs: a conceptual approach to elasticity and change in the global assisted reproduction industry	1
Suspending life, controlling change: cryotechnology, genetic identity, and ecological separation	1